European Medicines Agency approves fourth vaccine against COVID-19 – Old Continent – World – NOVA News

news/view/2021/03/11/318855/%D0%B5%D0%B2%D1%80%D0%BE%D0%B0%D0%B3%D0%B5%D0%BD%D1%86%D0%B8%D1%8F%D1%82%D0%B0-%D0%BF%D0%BE-%D0%BB%D0%B5%D0%BA%D0%B0%D1%80%D1%81%D1%82%D0%B2%D0%B0%D1%82%D0%B0-%D0%BE%D0%B4%D0%BE%D0%B1%D1%80%D0%B8-%D1%87%D0%B5%D1%82%D0%B2%D1%8A%D1%80%D1%82%D0%B0-%D0%B2%D0%B0%D0%BA%D1%81%D0%B8%D0%BD%D0%B0-%D1%81%D1%80%D0%B5%D1%89%D1%83-covid-19/">

It is given in one dose

The European Medicines Agency has approved another vaccine for use in the EU. It is a preparation of Johnson & Johnson, which is put in one dose.

So far, this vaccine has been tested on 44,000 people. It has been proven that two weeks after the immunization, 67 percent of the vaccinated were prevented from serious illness, BTA reports. The vaccine is recommended for adults, and the side effects are mild to moderate – fatigue, dizziness, muscle aches and headaches – and last up to several days.

Janssen is the fourth product approved in the EU since the European Commission ruled. Earlier today, the European Medicines Agency announced that it was launching an evaluation of a drug against COVID-19.

ASK ABOUT THE VACCINES HERE

EVERYTHING ABOUT THE VACCINES AGAINST COVID-19 READ HERE

–